Exhibit 10.22
[*] = CERTAIN CONFIDENTIAL
INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS
AMENDED.
AGREEMENT
This AGREEMENT is effective this
17th day of March, 2003, by and between Hoku Scientific, Inc.
(“HOKU”), whose address is 2153 North King Street,
Suite 306, Honolulu, Hawaii 96819, United States of America, and
Sanyo Electric Company, Ltd. (“SANYO”), whose address
is 1-18-13, Hashiridani Hirakata-City, Osaka 573-8534, Japan. HOKU
and SANYO are sometimes referred to herein individually as a
“Party” and collectively as “the
Parties”.
WHEREAS, HOKU and SANYO have engaged
in discussions regarding a relationship between the Parties and an
investment by SANYO in HOKU; and
WHEREAS, HOKU and SANYO desire to
enter into an agreement based on previous discussions between the
Parties.
NOW, THEREFORE, in consideration of
the mutual promises, covenants and agreements hereinafter
contained, the parties hereto agree as follows:
|
|
a.
|
Catalyst : Catalyst is a component of the Fuel Cell that
helps to initiate and maintain the electrochemical reaction needed
to generate electricity. Catalyst is typically precious
metals-based but may consist of other low cost
materials.
|
|
|
b.
|
Catalyst
Binding : Catalyst
Binding means the process used to attach the Catalyst to the
Catalyst Support.
|
|
|
c.
|
Catalyst
Support : Catalyst
Support is the backing used to support the Catalyst in the context
of a Fuel Cell. The Catalyst Support and Catalyst together make up
an Electrode.
|
|
|
d.
|
Electrode : Electrodes consist of a Catalyst and a
Catalyst Support. In Fuel Cells, Electrodes are located on either
side of a Membrane.
|
|
|
e.
|
Formulation : Formulation is a prescription of ingredients
in fixed proportion; a recipe.
|
|
|
f.
|
Fuel
Cell : A Fuel Cell is an
electrochemical device that combines a fuel such as hydrogen,
methanol, or others with an oxidant such as oxygen. The result is
electricity, heat, and water.
|
|
|
g.
|
Hoku
Membrane ™ : Hoku Membrane ™ is defined as all Formulations of the Membranes
developed by HOKU for use in an electrochemical device such as a
Fuel Cell. The Hoku Membrane ™ is typically used as a Proton Exchange Membrane
in Fuel Cells.
|
|
|
h.
|
Joint
Laboratory : The Joint
Laboratory is the laboratory facility that will house the single
cell and limited short stack testing associated with Phase I of
this Agreement, as indicated in Exhibit A. The Joint Laboratory
will be located at the HOKU facilities in Honolulu, Hawaii. Only
Research and Development Equipment associated with Phase I of this
Agreement will be housed in the Joint Laboratory. This includes,
but is not limited, to Single Cell and Stack testing
equipment.
|
|
|
i.
|
Liquid Hoku
Membrane ™ : Liquid Hoku Membrane ™ is defined as all Formulations of the Liquid
Membranes developed by HOKU for use in an electrochemical device
such as a Fuel Cell. It is a type of Liquid Membrane or Membrane
Paint.
|
|
|
j.
|
Liquid
Membrane : Liquid
Membrane (sometimes called Membrane Paint) is used to combine the
Catalyst on the Electrode with the Membrane for use in Fuel Cells.
This can be painted onto the surface of the Catalyst or the other
components of a Fuel Cell as part of the MEA, and can serve to
increase Fuel Cell performance.
|
|
|
|
|
|
|
|
SANYO’s
Initials & Date /s/ FT 17 Mar. ‘03
|
|
HOKU’s
Initials & Date /s/ DS 20 Mar. ‘03
|
|
1
|
[ * ] = CERTAIN CONFIDENTIAL
INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS
AMENDED.
|
|
k.
|
MEA :
MEA stands for Membrane Electrode Assembly and represents a
finished product that typically contains Electrodes adhered to both
sides of a Membrane. An MEA may also incorporate Liquid Membrane or
Membrane Paint.
|
|
|
l.
|
MEA Assembly
Process : MEA Assembly
Process pertains to the procedures, the Research and Development
Equipment, and the methods entailed in the use of this equipment,
that are required to build an MEA.
|
|
|
m.
|
Membrane : Membranes in the context of Fuel Cells
separate the system into two halves and help to initiate and
maintain the electrochemical reaction which generates
electricity.
|
|
|
n.
|
Membrane
Paint : Membrane Paint
has the same meaning as Liquid Membrane (see Liquid Membrane
definition).
|
|
|
o.
|
Production
Equipment : Production
Equipment includes all equipment required for the fabrication of
the Hoku Membrane ™ in accordance with this Agreement, including but
not limited to hot presses, injection molders, and
mixers.
|
|
|
p.
|
Proton
Exchange Membrane : A
Proton Exchange Membrane is a Membrane utilized in a Proton
Exchange Membrane Fuel Cell.
|
|
|
q.
|
Research and
Development Supplies :
Research and Development Supplies includes all materials and
reagents required to support joint testing in accordance with this
Agreement, including but not limited to electrode material, gases,
and synthesis chemicals.
|
|
|
r.
|
Research and
Development Equipment :
Research and Development Equipment includes all equipment required
to support joint testing in accordance with this Agreement
including but not limited test stations, MEA assembly equipment,
spectrometers, and other testing equipment.
|
|
|
s.
|
Single
Cell : Single Cell is a
Fuel Cell that utilizes a single MEA to generate power.
|
|
|
t.
|
Stack : A Stack is a Fuel Cell that contains two or
more Single Cells connected in series. Fuel Cell Stacks are
utilized to generate more power than a Single Cell can
generate.
|
|
|
a.
|
The Parties
agree to work together to achieve the objectives stated
below:
|
|
|
i.
|
Develop and
optimize an MEA Assembly Process incorporating the Hoku
Membrane ™ and the Liquid Hoku Membrane
™
.
|
|
|
b.
|
To do so, the
Parties shall follow the work plan attached as Exhibit
A.
|
|
|
c.
|
Joint
development will commence at the Joint Laboratory located at the
HOKU facilities in Honolulu, Hawaii. All work pertaining to Phase I
of this Agreement shall be conducted in the Joint Laboratory at the
HOKU facilities. No HOKU development activities other than the
joint development efforts described in this Agreement shall be held
in the Joint Laboratory. SANYO personnel will need to be
accompanied by HOKU personnel to enter into any of the HOKU
research and development facilities other than the Joint
Laboratory. Joint development Phases II and III will be completed
at the SANYO facilities in Gunma, Japan. The timing and location of
all joint development efforts are described in Exhibit
A.
|
|
3.
|
Responsibilities of the Parties.
|
|
|
a.
|
[ *
] responsibility for all
Agreement costs as defined by Exhibit B. Exhibit B describes any
and all assignable costs associated with this Agreement. Costs not
covered in Exhibit B cannot be charged to the other
Party.
|
|
|
b.
|
Responsibility
for the filing of technology patents shall be as
follows:
|
|
|
i.
|
[ *
] shall be responsible
for filing any and all patents for technology owned exclusively by
[ * ] as defined in Exhibit C.
|
|
|
|
|
|
|
|
SANYO’s
Initials & Date /s/ FT 17 Mar. ‘03
|
|
HOKU’s
Initials & Date /s/ DS 20 Mar. ‘03
|
|
Page 2 of 15
|
[ * ] = CERTAIN CONFIDENTIAL
INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS
AMENDED.
|
|
ii.
|
[ *
] shall be responsible
for filing any and all patents for technology owned exclusively by
[ * ] as defined in Exhibit C, and for the specific MEA
Assembly Process jointly owned by the Parties in accordance with
this Agreement, as defined in Exhibit C.
|
|
|
iii.
|
Any patents
filed by [ * ] for the specific MEA Assembly Process jointly
owned by the Parties that refers to the Hoku Membrane
™ and/or the Liquid Hoku Membrane
™
, shall be specific to a particular
Formulation of the Hoku Membrane ™ and/or a particular Formulation of the Liquid
Hoku Membrane ™ .
|
|
|
iv.
|
[ *
] shall file patent
applications for the specific MEA Assembly Process owned jointly by
the Parties within three months of its discovery or implementation.
[ * ] shall file, prosecute, and maintain these patent
applications at its sole discretion and at its expense, and at a
minimum, in any country where the MEA will be sold. [ * ]
will provide [ * ] the documents submitted to or received
from the Patent Office for filing, prosecuting, or maintaining such
patent applications. After the three months from discovery or
implementation, if [ * ] at its sole discretion chooses not
to file a patent on a particular technology, [ * ] may file
a patent at its sole expense and claim full ownership to that
particular technology.
|
|
|
v.
|
All patents for
the specific MEA Assembly Process owned jointly by the Parties,
regardless of filing date or country, shall name both HOKU and
SANYO as joint developers on the patents, except as described above
in 3.b.iv.
|
|
|
vi.
|
SANYO shall use
its best efforts to promote and sell the MEA produced in accordance
with the specific MEA Assembly Process jointly owned by the
Parties.
|
|
|
c.
|
Responsibility
for defending technology patents shall be as follows:
|
|
|
i.
|
[ *
] shall be responsible
for the legal fees and any other costs associated with maintaining
and defending all patents associated with technology owned
exclusively by [ * ] .
|
|
|
ii.
|
[ *
] shall be responsible
for the legal fees and any other costs associated with maintaining
and defending all patents associated with technology owned
exclusively by [ * ] , and for the specific MEA Assembly
Process jointly owned by the Parties.
|
|
|
d.
|
The Parties
agree to notify each other immediately if they identify any
potential or actual patent infringements.
|
|
|
a.
|
The
Parties’ intellectual property rights associated with this
Agreement are described in full at Exhibit C.
|
|
|
b.
|
SANYO shall
have the exclusive worldwide right and license to manufacture,
market, and sell the MEA produced in accordance with the specific
MEA Assembly Process jointly owned by the Parties in accordance
with this Agreement. SANYO shall not have the right to develop,
reverse engineer, manufacture, market, or sell the Hoku
Membrane ™ , Liquid Hoku Membrane ™ , or any other technology owned exclusively by
HOKU, without written consent by HOKU.
|
|
|
c.
|
SANYO shall
have the right to grant sublicenses with respect to MEA production
in accordance with the specific MEA Assembly Process jointly owned
by the Parties, including
|
|
|
|
|
|
|
|
SANYO’s
Initials & Date /s/ FT 17 Mar. ‘03
|
|
HOKU’s
Initials & Date /s/ DS 20 Mar. ‘03
|
|
Page 3 of 15
|
[ * ] = CERTAIN CONFIDENTIAL
INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS
AMENDED.
MEA manufacturing. SANYO shall
disclose all sublicenses to HOKU and work with HOKU to maintain the
confidentiality of all Confidential Information. Sanyo shall be
liable for any unauthorized disclosure of any HOKU confidential
information to or by a company that SANYO sublicenses production
to.
|
|
d.
|
HOKU maintains
the exclusive right to develop, manufacture, market, distribute,
and sell the Hoku Membrane ™ and any and all technologies developed solely by
HOKU, which may or may not be included in the MEA produced in
accordance with the specific MEA Assembly Process jointly owned by
the Parties in accordance with this Agreement.
|
|
|
e.
|
This Agreement
does not preclude SANYO from working alone or with a third party to
develop a different MEA Assembly Process from the specific MEA
Assembly Process jointly owned by the Parties in accordance with
this Agreement (“SANYO MEA Assembly Process”), or from
manufacturing, marketing, and selling MEAs that are produced in
accordance with this SANYO MEA Assembly Process. The SANYO MEA
Assembly Process must be based on technology owned exclusively by
SANYO. The SANYO MEA Assembly Process may not be based on
technology owned exclusively by HOKU.
|
|
|
f.
|
This Agreement
does not preclude HOKU from working alone or with a third party to
develop a different MEA Assembly Process from the specific MEA
Assembly Process jointly owned by the Parties in accordance with
this Agreement (“HOKU MEA Assembly Process”), or from
manufacturing, marketing, and selling MEAs that are produced in
accordance with this HOKU MEA Assembly Process. The HOKU MEA
Assembly Process must be based on technology owned exclusively by
HOKU. The HOKU MEA Assembly Process may not be based on technology
owned exclusively by SANYO.
|
|
|
g.
|
The Parties
agree to allow each other to use the others’ name for
purposes of furthering their business and developing business
partnerships with other companies or corporations. This includes,
but is not limited to, press releases, media quotes and paid
advertising. Each Party agrees to seek and receive from the other
Party prior approval for any use of the other Party’s
name.
|
|
|
a.
|
In exchange for
the rights acquired by SANYO and described in Section 4 above,
SANYO agrees to the following:
|
|
|
i.
|
Cash payment of
two million five hundred thousand US dollars ($2,500,000) to HOKU
as detailed in Exhibit D. Cash Payment is defined as a development
fee being paid to HOKU by SANYO.
|
|
|
ii.
|
The Parties
agree to discuss an equity investment in HOKU by SANYO in the
amount of at least one million US dollars ($1,000,000). The Parties
Agree to put forth its best efforts to execute this equity
investment by April 15, 2003. Both Parties agree that not doing so
would negatively affect the chances of a successful business
outcome with respect to this Agreement.
|
|
|
iii.
|
The dates
listed in Exhibit D are dates agreed upon by the Parties. Cash
payments associated with a milestone are indicated as such in
Exhibit D.
|
|
|
|
|
|
|
|
SANYO’s
Initials & Date /s/ FT 17 Mar. ‘03
|
|
HOKU’s
Initials & Date /s/ DS 20 Mar. ‘03
|
|
Page 4 of 15
|
[ * ] = CERTAIN CONFIDENTIAL
INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS
AMENDED.
|
6.
|
Equipment
and Resources.
|
|
|
a.
|
[ *
] shall identify and
purchase all reasonable Research and Development Equipment, except
for the equipment identified in Section 6.b. below, to complete
Phase I of this Agreement. Equipment described in this section will
be housed at the Joint Laboratory in Honolulu, Hawaii.
|
|
|
b.
|
[ *
] shall provide all
essential equipment pertaining to MEA assembly and test cells for
use in Phase I of this Agreement, and pay any shipping costs
required to relocate this equipment from the [ * ]
facilities to the Joint Laboratory in Honolulu, Hawaii.
|
|
|
c.
|
[ *
] shall identify and make
available, or purchase, all reasonable Research and Development
Equipment required to complete Phases II and III of this Agreement.
This equipment will be housed at the SANYO facilities in Gunma,
Japan.
|
|
|
d.
|
All equipment
purchased by [ * ] in accordance with this Agreement and
described above at 6.b. and 6.c. shall belong to [ * ]
regardless of the outcome of this Agreement.
|
|
|
e.
|
All equipment
purchased by [ * ] in accordance with this Agreement and
described above at 6.a. shall belong to [ * ] regardless of
the outcome of this Agreement.
|
|
7.
|
Confidential
Information.
|
|
|
a.
|
The term
“Confidential Information” shall include all
confidential or proprietary information and data furnished by
either Party to the other, whether in oral, written, graphic or
machine-readable form, including but not limited to, product or
sample product, designs, procedures, formulas, discoveries,
inventions, improvements, concepts, and ideas, except such
information and data as the parties agree in writing is not
proprietary or confidential. Confidential Information should be
marked as “Confidential” or “Proprietary”
or such similar wording at the time of disclosure by the disclosing
party (the “Disclosing Party”) or orally identified as
such at the time of disclosure by the Disclosing Party to the other
party (the “Receiving Party”).
|
|
|
b.
|
“Confidential Information” shall not
include any information or data furnished by the Disclosing Party
that (a) was in the public domain at the time it was communicated
to the Receiving Party; (b) entered the public domain subsequent to
the time it was communicated to the Receiving Party through no
fault of the Receiving Party; (c) was in the Receiving
Party’s possession free of any obligation of confidence at
the time it was communicated to the Receiving Party; (d) was
rightfully communicated to the Receiving Party free of any
obligation of confidence subsequent to the time it was communicated
by the Disclosing Party to the Receiving Party.
|
|